SCHEMBL7654217

SCHEMBL7654217

CS(=O)(=O)OC/C=C\I

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5487261 1.00
SCHEMBL5487266 1.00
SCHEMBL4465846 0.84 USP2 (0.48)
SCHEMBL6118063 0.84 USP2 (0.48)
SCHEMBL4465842 0.84 USP2 (0.48)
SCHEMBL7480573 0.77
SCHEMBL7480571 0.77
SCHEMBL9425788 0.75
SCHEMBL4361309 0.75 USP2 (0.40)
SCHEMBL11128431 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6384045-B1 TREATMENT OF ALZHEIMER'S DISEASE AND ANTICANCER AGENTS KANSAS STATE UNIVERSITY RESEARCH FOUNDATION 2002-05-07 US disclosed
US-5958970-A ENZYME INHIBITORS OF ACETYLCHOLINESTERASE (ACHE) AND ACYL-COA:CHOLESTEROL ACYLTRANSFERASE (ACAT); USED IN THE TREATMENT OF ALZHEIMER'S DISEASE, ATHEROSCLEROSIS AND HYPERCHOLESTEROLEMIA KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) 1999-09-28 US disclosed